| Connie Man, PHARMD | |
|
6170 Thornton Ave Ste E, Newark, CA 94560-3700 | |
| (510) 961-1288 | |
| Not Available |
| Full Name | Connie Man |
|---|---|
| Gender | Female |
| Speciality | Pharmacy - Community/retail Pharmacy |
| Location | 6170 Thornton Ave Ste E, Newark, California |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1598048621 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 183500000X | Pharmacist | 68608 (California) | Secondary |
| 3336C0003X | Pharmacy - Community/retail Pharmacy | 57708 (California) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Connie Man, PHARMD 6170 Thornton Ave Ste E, Newark, CA 94560-3700 Ph: (510) 961-1288 | Connie Man, PHARMD 6170 Thornton Ave Ste E, Newark, CA 94560-3700 Ph: (510) 961-1288 |
News Archive
Novo Nordisk announced today that a Biologic License Application has been submitted to the U.S. Food and Drug Administration requesting the approval of a recombinant factor XIII compound for the vast majority of patients with congenital factor XIII deficiency, an inherited bleeding disorder.
Genome editing is fast becoming a norm with more and more research teams working on this arena and coming up with new cutting edge developments. However attitudes towards genetic modifications vary with several opinions – political, moral and religious, raising concerns.
RoundTable Healthcare Partners, an operating-oriented private equity firm focused exclusively on the healthcare industry, announced today that it has completed the sale of Bioniche Pharma Holdings Limited to Mylan Inc., a leading, global generic and specialty pharmaceutical company, for $550 million in cash.
U.S. Congressman James McGovern, State Representative Elizabeth Poirier and local dignitaries joined Theragenics Corporation executives in ribbon cutting ceremonies on October 15 for a new 73,000-square foot manufacturing facility for the company's subsidiary, NeedleTech Products. The new facility increases NeedleTech's production area by 30% or 20,000 square feet, allowing the company to consolidate two separate older facilities into one location. The new building will allow NeedleTech to expand operations, increase R&D and offer more services to its customers.
Community Health Centers are providing a growing number of newly uninsured people with primary and preventive care. These centers are being tested by the growing patient load, MarketWatch reports.
› Verified 8 days ago